These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6115916)

  • 21. The actions of amphetamine on neurotransmitters: a brief review.
    Moore KE
    Biol Psychiatry; 1977 Jun; 12(3):451-62. PubMed ID: 17437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationships between selective denervation of dopamine terminal fields in the anterior forebrain and behavioral responses to amphetamine and apomorphine.
    Fink JS; Smith GP
    Brain Res; 1980 Nov; 201(1):107-27. PubMed ID: 7191345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The influence of calcium channel blockers on the effects of haloperidol and phenamine in mice and rats].
    Kozlovskiĭ VL; Prakh'e IV; Kenunen OG
    Eksp Klin Farmakol; 1996; 59(3):12-5. PubMed ID: 8974575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pathophysiology of tardive dyskinesia.
    Klawans HL; Carvey P; Tanner CM; Goetz CG
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):38-41. PubMed ID: 2858479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of insulin hypoglycemia on central dopaminergic structures of the rat.
    Kleinrok Z; Ossowska G; Stelmasiak M; Juszkiewicz M
    Pol J Pharmacol Pharm; 1983; 35(6):489-95. PubMed ID: 6377282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enduring changes in dopamine receptor cells of pups from drug administration to pregnant and nursing rats.
    Rosengarten H; Friedhoff AJ
    Science; 1979 Mar; 203(4385):1133-5. PubMed ID: 570724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SCH-23390: a selective D1 dopamine antagonist with potent D2 behavioral actions.
    Mailman RB; Schulz DW; Lewis MH; Staples L; Rollema H; Dehaven DL
    Eur J Pharmacol; 1984 May; 101(1-2):159-60. PubMed ID: 6235121
    [No Abstract]   [Full Text] [Related]  

  • 28. Amphetamine-haloperidol interactions in rat striatum: failure to correlate behavioral effects with dopaminergic and cholinergic dynamics.
    Kuczenski R; Schmidt D; Leith N
    Brain Res; 1977 Apr; 126(1):117-29. PubMed ID: 558038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behavioral evidence for dopamine receptor subsensitivity following chronic haloperidol.
    Lynch MR
    Neuropsychobiology; 1990-1991; 24(2):102-8. PubMed ID: 2151972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of l-stepholidine on rotational behavior in rats].
    Shi WX; Chen Y; Jin GZ
    Zhongguo Yao Li Xue Bao; 1984 Dec; 5(4):222-5. PubMed ID: 6242210
    [No Abstract]   [Full Text] [Related]  

  • 31. Dopaminergic influence on the effects of angiotensin II in behavioural reactions.
    Georgiev V; György L; Yonkov D; Getova D; Markovska V; Petkova B
    Physiol Bohemoslov; 1985; 34 Suppl():45-8. PubMed ID: 3014581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of 7-hydroxy-N,N-di-n-propylaminotetralin on behaviour and blood pressure of spontaneously hypertensive rats.
    Van den Buuse M
    Eur J Pharmacol; 1993 Oct; 243(2):169-77. PubMed ID: 8276066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presence of a particular subpopulation of dopamine receptors within the septal nuclei: a behavioural study on cats.
    Megens AA; Cools AR
    Eur J Pharmacol; 1981 May; 71(2-3):247-58. PubMed ID: 6265235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation and biological actions of some symmetrically N,N-disubstituted dopamines.
    Cannon JG; Hsu FL; Long JP; Flynn JR; Costall B; Naylor RJ
    J Med Chem; 1978 Mar; 21(3):248-53. PubMed ID: 564406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Action of fibrinopeptides A and B on the central dopaminergic system of rats pretreated with indomethacin.
    Swiderska D; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1986; 38(1):21-8. PubMed ID: 3763484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel long-lasting dopamine receptor blocker: haloperidol-bovine serum albumin conjugate.
    Garrigues AM; Stinus L; Taghzouti K; Simon H; Le Moal M; Delaage M
    Eur J Pharmacol; 1985 Dec; 118(3):313-9. PubMed ID: 4085558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neurophysiologic and pharmacologic evidence of autoregulationin the nigrostriatal system].
    Arushanian EB; Tolpyshev BA
    Biull Eksp Biol Med; 1981 Feb; 91(2):133-6. PubMed ID: 7194700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential enhancement of behavioral sensitivity to apomorphine following chronic treatment of rats with (-)-sulpiride and haloperidol.
    Montanaro N; Dall'Olio R; Gandolfi O; Vaccheri A
    Eur J Pharmacol; 1982 Jun; 81(1):1-9. PubMed ID: 6889533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioral pharmacologic studies in the monkey with DD-3480.
    Shibuya T; Nishimori T; Matsuda H; Chen PC
    Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):251-4. PubMed ID: 6125481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic lithium treatment and dopamine-mediated behavior.
    Ebstein RP; Eliashar S; Belmaker RH; Ben-Uriah Y; Yehuda S
    Biol Psychiatry; 1980 Jun; 15(3):459-67. PubMed ID: 7189675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.